35 years market-leading expertise in the import and trade of high-quality pharmaceuticals: The MPA Pharma group comprises the ... pharmaceuticals manufacturer MPA Pharma GmbH and its subsidiaries EMRAmed Arzneimittel GmbH, the distributor for the German-speaking world, and Paranova Group A/S, distributor for the Scandinavian countries Denmark, Sweden, Finland and Norway. MPA Pharma group's core activities are in the reimport and parallel import of EU medicinal products, trade with pharmaceuticals and medical devices, as well as contract manufacturing services for third parties. Our strong partnership ethic in dealings with customers, the long-standing expertise of our around 630 employees and our comprehensive product range form the basis of our business relationships. Safety and quality: MPA Pharma stands for premium quality and professionalism. MPA Pharma is an authorised manufacturer of pharmaceuticals and hence subject to the highest quality assurance standards. We monitor and document all steps of the process, from researching new EU pharmaceuticals through to the delivery of all pharmaceuticals in pristine condition. National laws and European guidelines: All EU pharmaceuticals produced by MPA Pharma and distributed by its subsidiaries EMRAmed and Paranova comply with the relevant national drug law or the requirements of the European Medicines Agency: The distribution of nationally licensed EU pharmaceuticals in the form of parallel imports requires the approval of the national competent authorities. For centrally authorised pharmaceuticals, a notice of a completed notification procedure must be granted by the European Medicines Agency. At MPA Pharma, every step in the production process conforms both to good manufacturing practices (GMP) and legal requirements of the applicable national regulations. Our pharmaceuticals are delivered in line with good distribution practices (GDP) and legal requirements of the applicable national regulations. read more